Nosocomial cardiac infections

Journal of Hospital Infection

Volumn 50, Issue 2, 2002, Pages 91-105

  Giamarellou, H ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Implantable cardiac assist devices; Nosocomial endocarditis; Nosocomial infections; Pace maker; Prosthetic heart valves

Indexed keywords

ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; CEFAZOLIN; CEFUROXIME; CEPHALOSPORIN; CLINDAMYCIN; GENTAMICIN; PENICILLIN G; RIFAMPICIN; VANCOMYCIN;

ARTIFICIAL HEART PACEMAKER; BACTEREMIA; BACTERIAL ENDOCARDITIS; BLOOD CULTURE; CANDIDA; CANDIDIASIS; COMORBIDITY; DEFIBRILLATOR; DISEASE ASSOCIATION; DISEASE SEVERITY; FOREIGN BODY; GASTROINTESTINAL SURGERY; HEART LEFT VENTRICLE; HEART VALVE PROSTHESIS; HIGH RISK PATIENT; HOSPITAL; HOSPITAL ADMISSION; HOSPITAL INFECTION; HUMAN; IMPLANTATION; INCIDENCE; INFECTION RISK; INTRAVASCULAR CATHETER; MEDICAL INSTRUMENTATION; MORBIDITY; MORTALITY; PATHOGENESIS; PRACTICE GUIDELINE; REVIEW; SKIN INFECTION; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; SURGICAL TECHNIQUE; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; UROLOGIC SURGERY; WOUND INFECTION; CROSS INFECTION; ENDOCARDITIS; HEART ASSIST DEVICE; MICROBIOLOGY; PROGNOSIS; STAPHYLOCOCCUS INFECTION; SURVIVAL RATE; VALVULAR HEART DISEASE;

CANDIDIASIS; CROSS INFECTION; DEFIBRILLATORS, IMPLANTABLE; ENDOCARDITIS; ENDOCARDITIS, BACTERIAL; HEART VALVE DISEASES; HEART VALVE PROSTHESIS; HEART-ASSIST DEVICES; HUMANS; PROGNOSIS; STAPHYLOCOCCAL INFECTIONS; SURVIVAL RATE;

EID: 0036482036     PISSN: 01956701     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhin.2001.1144     Document Type: Article

References (86)

1. Sobel JD Nosocomial infective endocarditis In: Kaye D (Ed.), Infective Endocarditis, 2nd edn. 1992 361-373 Raven Press, Ltd New York
2. Gilleece A Fenelon L Nosocomial infective endocarditis J Hosp Inf 46 2000 83-88
3. Horan TC White JW Jarvis WR et al. Nosocomial infection surveillance, 1984 MMWR 35 1986 17SS-29SS
4. Terpenning MS Buggy B Kauffman CA Hospital-acquired infective endocarditis Arch Intern Med 148 1988 1601-1603
5. Chen S Dwyer D Sorrell T A comparison of hospital and community-acquired infective endocarditis Am J Cardiol 70 1992 1449-1452
6. Fernandez-Guerrero M Verdejo C Azofra M de Gorgolas M Hospital-acquired infectious endocarditis not associated with cardiac surgery: an emerging problem CID 20 1995 16-23
7. Friedland G von Reyn F Levy B Arbeit R Dasse P Crumpacker C Nosocomial endocarditis Inf Control 5 1984 284-288
8. Guze L Pearce M Hospital-acquired bacterial endocarditis Arch Intern Med 112 1963 56-62
9. Watanakunakorn C Staphylococcus aureus endocarditis at a community teaching hospital, 1980-1991 Arch Intern Med 154 1994 2330-2335
10. Gilleece A Buckley A Quigley P Fenelon L Infective endocarditis: evaluation of the Duke criteria and transoesophageal echocardiography for the diagnosis of endocarditis J Infection 36 1998 A10
11. Garvey GJ Neu HC Infective endocarditis-an evolving disease: a review of endocarditis at the Columbia-Presbyterian Medical Center, 1968-1973 Medicine (Baltimore) 57 1978 105-127
12. Watanakunakorn C Burkert T Infective endocarditis at a large community teaching hospital, 1980-1990. A review of 210 episodes Medicine (Baltimore) 72 1993 90-102
13. Kazanjian PH Infective endocarditis: review of 60 cases treated in community hospitals Infect Dis Clin Pract 2 1993 41-46
14. Pittet D Nosocomial bloodstream infections In: Wenzel R (Ed.), Prevention and Control of Nosocomial Infections, 3rd edn. 1997 711-769 Williams & Wilkins Publishers
15. Rowley KM Clubb KS Smith GJW et al. Right-sided infective endocarditis as a consequence of flow directed pulmonary artery catheterization, N Engl J Med 311 1984 1152-1156
16. Gilleece A Fenelon L Increasing incidence of coagulase negative staphylococcal endocarditis J Infection 36 1998 A22
17. Banerjee SN Emori TG Culver DH et al. Secular trends in nosocomial primary bloodstream infections in the United States, 1980-1989, National Nosocomial Infections Surveillance System Am J Med 91 1991 86S-89S
18. Espersen F Frimodt-Møller N Staphylococcus aureus endocarditis. A review of 119 cases Arch Intern Med 146 1986 1118-1121
19. Sanabria TJ Alpert JS Goldberg R Pape LA Cheeseman SH Increasing frequency of staphylococcal infective endocarditis, Experience at a university hospital, 1981 through 1988 Arch Intern Med 150 1990 1305-1309
20. Fang G Keys TF Gentry LO et al. Prosthetic valve endocarditis resulting from nosocomial bacteremia. A prospective, multicenter study Ann Intern Med 119 1993 560-567
21. Mugge A Echocardiographic defection of cardiac valve vegetations and prognostic implications Inf Dis Clic North Am 7 1993 877-898
22. Daniel WG Mugge A Transesophageal echocardiography N Engl J Med 332 1995 1268-1279
23. Fowler Jr VG Li J Corey GR et al. Role of echocardiography in the evaluation of patients with Staphylococcus aureus bacteremia: experience in 103 patients J Am Coll Cardiol 30 1997 1072-1078
24. Foweler VG Sanders LL Li Kuo Kong R et al. Infective endocarditis due to Staphylococcus aureus: 59 perspectively identified cases with follow-up CID 28 1999 106-114
25. Graham DR Keldermans MM Klemm LW Semenza NJ Shafer ML Infectious complications among patients receiving home intravenous therapy with peripheral, central, or peripherally placed venous catheters Am J Med 91 1991 95S-100S
26. Watanakunakorn C Editorial response: Increasing importance of intravascular device-associated Staphylococcus aureus eudocarditis CID 28 1999 115-116
27. Rosen AB Fowler VG Corey R et al. Cost-effectiveness transesophageal echocardiography to determine the duration of therapy for intravascular catheter-associated Staphylococcus aureus bacteremia Ann Intern Med 130 1999 810-820
28. Chambers HF Short-course combination and oral therapies of Staphylococcus aureus endocarditis Infect Dis Clin North Am 7 1993 69-80
29. Hernández P. González T. Aguado JM. Hernández F. Serious consequences of nosocomial infective endocarditis in patients without cardiac prosthesis, 6th International Symposium on Modern Concepts in Endocarditis and Cardiovascular Infections, June 27-29, 2001, Sitges (Barcelona), Spain. Abst P047
30. Maki DG Agger WA Enterococcal bacteraemia: clinical features, the risk of endocarditis, and management Medicine 67 1988 248-269
31. Megran DW Enterococcal endocarditis CID 15 1992 63-71
32. Sijpkens Y Buurke E Urlich C van Asselt G Enterococcus faecalis colonisation and endocarditis in five intensive care patients as late sequelae of selective decontamination Intensive Care Med 21 1995 231-243
33. Venditti M Biavasco F Veraldo P et al. Catheter-related endocarditis due to glycopeptide-resistant Enterococcus faecalis in a transplanted heart CID 17 1993 524-525
34. Pérez-Salmerón, A. Martinez-Garcia, F, Roldán, D, et al., Efficacy of quinupristin-dalfopristin alone or in combination with gentamicin, teicoplanin and imipenem in treatment of experimental endocarditis due to β-lactam and glycopeptide-resistant Enterococcus faecium, 6th International Symposium on Modern Concepts in Endocarditis and Cardiovascular Infections. June 27-29, 2001, Sitges (Barcelona), Spain. Abst P021
35. Garcia de la Maria C Miro JM Marco F et al. In vitro activity of vancomycin or linezolid plus oxacillin or imipenem against methicillin-resistant and glycopeptide intermediate Staphylococcus aureus (GISA), 6th International Symposium on Modern Concepts in Endocarditis and Cardiovascular Infections. June 27-29, 2001, Sitges (Barcelona), Spain. Abst P023
36. Finkelstein R Boulus M MarKievicz M et al. Hospital-acquired Pseudomonas aeruginosa endocarditis J Hosp Inf 18 1991 161-163
37. Fichtenbaum CJ Smith MJ Treatment of endocarditis due to Pseudomonas aeruginosa with imipenem CID 14 1992 353-364
38. Ellis ME Al-Abdely H Sandridge A Greer W Ventura W Fungal endocarditis: evidence in World literature, 1965-1995 CID 32 2001 50-62
39. Rubinstein E Lang R Fungal endocarditis Eur Heart J 16 1995 (Suppl B) S84-S89
40. Nasser R Melgar G Longworth D Gordon S Incidence and risk of developing fungal prosthetic valve endocarditis after nosocomial candidaemia Am J Med 103 1997 25-32
41. Maisch PA Calderone RA Adherence of Candida albicans to a fibrinogen-platelet matrix formed in vitro Infect Immun 27 1980 650-656
42. Pittet D Wenzel R Nosocomial bloodstream infections: Secular trends in rates, mortality, and contribution to hospital deaths Arch Intern Med 155 1995 1117-1183
43. Weems Jr JJ Candida parapsilosis: Epidemiology, pathogenicity, clinical manifestations and antimicrobial susceptibility CID 14 1992 756-766
44. Hawser SP Douglas LJ Biofilm formation by Candida species on the surface of catheter material in vitro Infect Immun 62 1994 915-921
45. Richardson MD Kokki MH New perspectives in the diagnosis of systemic fungal infections Ann Med 31 1999 327-335
46. Muehrcke DD Lythe BW Cosgrove DM Surgical and long-term antifungal therapy for fungal prosthetic valve endocarditis Ann Thorac Surg 60 1995 538-543
47. Ellis M Amphotericin B preparations: a maximum tolerated dose in severe fungal infections Transplant Infect Dis 2 2000 51-61
48. Karchmer AW Infections of prosthetic valves and intravascular devices In: Mandell GL Bennett JE Dolin R (Eds.), Principles and Practice of Infectious Disease, 5th edn. 2000 903-913 Churchill Livingtone Philadelphia
49. Fang G Keys TF Gentry LO et al Prosthetic valve endocarditis resulting from nosocomial bacteremia Ann Intern Med 119 1993 560-567
50. Sharr A Felwards M Mitral replacement: Clinical experience with a ball valve prosthesis Ann Surg 104 1961 726-740
51. Vlessis AA Khaki A Grunkemeier GL Li HH Starr A Risk, diagnosis and management of prosthetic valve endocarditis: A review J Heart Valve Dis 6 1997 443-465
52. Calderwood SB Swinski LA Karchmer AW Waternaux CM Morhmer JB Prosthetic valve endocarditis. Analysis of factors, affecting outcome of therapy J Thorac Cardiovasc Surg 92 1986 776-783
53. Lutwick LI Vaghjimal A Connoly MW Postcardiac surgery infections Crit Care Clin 14 1998 221-200
54. Calderwood SB Swinski LA Waternaux CM Risk factors for the development of prosthetic valve endocarditis Circulation 72 1985 31-37
55. Rutledge R Kim BJ Applebaum RE Actuarial analysis of the risk of prosthetic valve endocarditis in 1,596 patients with mechanical and bioprosthetic valves Arch Surg 120 1985 469-472
56. Hammermeister KG Sethi GK Henderson WG A comparison of outcomes eleven years after heart valve placement with a mechanical valve or prosthesis N Engl J Med 328 1993 1289-1296
57. Kluge RM Calia FM McLaughlin JS Hornick RB Sources of contamination in open heart surgery JAMA 230 1974 1415-1418
58. Blakemore WS Mc Garrily GJ Thucer RJ Infection by air-borne bacteria with cardiopulmonary bypass Surgery 70 1971 830-838
59. Archer GL Vishniavsky N Stiver HG Plasmid pattern analysis of Staphylococcus epidermidis isolates from patients with prosthetic valve endocarditis Infect Immun 35 1982 627-632
60. Tompkins LS Roessler BJ Redd SC et al Legionella prosthetic-valve endocarditis N Engl J Med 318 1988 530-535
61. Bloomfield P Wheatley DJ Prescott RJ et al. Twelve-year comparison of a Bjork-Shiley mechanical heart valve with porcine bioprosthesis N Engl J Med 324 1991 573-579
62. Chen SC Sorrell TC Dwyer DE Endocarditis associated with prosthetic cardiac valves Med J Aust 152 1990 458-463
63. Keys TF Early-onset prosthetic valve endocarditis Cleve Clin J Med 60 1993 455-459
64. Karchmer AW Archer GJ Dismukes WE Staphylococcus epidermidis causing prosthetic valve endocarditis: Microbiologic and clinical observation as guides to therapy Ann Intern Med 98 1983 447-455
65. Ivert T Dismukes W Cobb C Blackstone E Kirklin J Bergdahl L Prosthetic valve endocarditis Circulation 69 1984 223-232
66. Johnston BL Schlech WF Marrie TJ An outbreak of Candida parapsilosis prosthetic valve endocarditis following cardiac surgery J Hosp Inf 28 1994 103-112
67. Wolff M Witchitz S Chastang C et al. Prosthetic valve endocarditis in the ICU: Prognostic factors of overall survival in a series of 122 cases and consequences for treatment decision Chest 108 1995 688-694
68. Vered Z Mossinson D Peleg E et al. Echocardiographic assessment of prosthetic valve endocarditis Eur Heart J 16 1995 63-67
69. Durack GT Lukes AS Bright DK and the Duke Endocarditis Service New criteria for diagnosis of infective endocarditis: Utilization of specific echocardiographic findings Am J Med 96 1994 200-209
70. Wareham DW Das S Solanki K Britton K Padhy A 99m Tc-Ciprofloxacin (Infecton) imaging of cardiovascular infections, 6th International Symposium on Modern Concepts in Endocarditis and Cardiovascular Infection. June 27-29, 2001, Sitges (Barcelona), Spain. Abst P099
71. David TE The surgical treatment of patients with prosthetic valve endocarditis Sem Thorac Cardiovasc Surg 7 1995 47-53
72. Klug D Lacroix D Savoye C et al. Systemic infection related to endocarditis on pacemaker leads. Clinical presentation and management Circulation 95 1997 2098-2107
73. Cacoub P Leprince P Nataf P Pacemaker infective endocarditis Amer J Cardiol 82 1998 480-484
74. Waldwogel F Pacemaker infections In: Bisno AL Waldvogel FA (Eds.), Infections Associated with Indwelling Mechanical Devices, 2nd edn. 1994 251-258 American Society for Microbiology Washington
75. Lewis AB Hayes DH Holmes Jr DR et al. Upadate on infections involving permanent pacemakers: Characterization and management J Thorac Cardiovasc Surg 89 1985 758-763
76. Arber N Pras E Copperman Y et al.Pacemaker endocarditis. Report of 44 cases and review of the literature Medicine 73 1994 299-305
77. Camus C Leport C Raffi F Michelet C Cartier F Vildé JL Sustained bacteremia in 26 patients with a permanent endocardial pacemaker: assessment of wire removal CID 17 1993 46-55
78. Spinler SA Navarskas JJ Foote EF et al. Clinical presentation and analysis of risk factors for infectious complications of implantable cardioverter-defibrillator implantations at a university medical center CID 26 1998 1111-1116
79. Lai KK Fontecchio SA Infections associated with implantable cardioverter-defibrillator placed transvenounsly and via thoracotomies: Epidemiology, infection, control and management CID 27 1998 265-267
80. Fischer SA Trenholme GM Gostanzo MR Piccione W Infectious complications in left ventricular assist device recipients CID 24 1997 18-23
81. Dajani A Taubert K Wilson W et al. Prevention of bacterial endocarditis Circulation 96 1997 358-366
82. Ehni W Reller L Short course therapy for catheter-associated Staphylococcus aureus bacteremia Arch Intern Med 149 1989 533-536
83. The Medical Letter on Drugs and Therapeutics Antimicrobial Prophylaxis in Surgery 41 1999 75-80
84. Hall JC Christiansen K Carter MJ et al. Antibiotic prophylaxis in cardiac operations Ann Thorac Surg 56 1993 916-922
85. Nooyen SM Overbeek BP Brutel de la Riviere A Storm AJ Langemey JJ Prospective randomised comparison of single-dose versus multi-dose cefuroxime for prophylaxis in coronary artery bypass grafting Eur J Clin Microbiol Infect Dis 13 1994 1033-1037
86. Da Costa A Kirkozian G Cucherat M et al. Antibiotic prophylaxis for permanent pacemaker implantation meta-analysis Circulation 97 1998 1796-1801